T\u00fcbingen\/ Hamburg \u2014 German health\u00adcare specia\u00adlist SHS Capi\u00adtal is selling its stake in Spie\u00adgel\u00adberg to Luciole Medi\u00adcal AG. Spie\u00adgel\u00adberg, a medi\u00adcal tech\u00adno\u00adlogy company based in Hamburg, Germany, deve\u00adlops, produ\u00adces and distri\u00adbu\u00adtes highly specia\u00adli\u00adzed cathe\u00adters and measu\u00adring probes for neuro\u00adsur\u00adgi\u00adcal appli\u00adca\u00adti\u00adons in the brain and has been able to grow stron\u00adgly in recent years. Luciole Medi\u00adcal AG, which specia\u00adli\u00adzes in cere\u00adbral moni\u00adto\u00adring and measu\u00adre\u00adment of oxygen satu\u00adra\u00adtion in the brain, expands its product range with the acqui\u00adsi\u00adtion of Spiegelberg<\/p>\n
Foun\u00added in 1986, Spie\u00adgel\u00adberg has become a reco\u00adgni\u00adzed provi\u00adder in the field of intra\u00adcra\u00adnial pres\u00adsure measu\u00adre\u00adment. Signi\u00adfi\u00adcant growth was gene\u00adra\u00adted during the holding period of SHS. Today, the company is one of the leading manu\u00adfac\u00adtu\u00adr\u00aders of ICP probes for intra\u00adcra\u00adnial pres\u00adsure measu\u00adre\u00adment as well as the produc\u00adtion of high-quality cathe\u00adters for ventri\u00adcu\u00adlar drai\u00adnage, subdu\u00adral drai\u00adnage or lumbar drai\u00adnage and matching exter\u00adnal ventri\u00adcu\u00adlar drai\u00adnage (EVD) sets. The company works with reco\u00adgni\u00adzed rese\u00adarch insti\u00adtu\u00adtes as well as leading clinics and specia\u00adlists in neuro\u00adsur\u00adgery to deve\u00adlop products that are best tail\u00ado\u00adred to the patient.<\/p>\n
With Luciole Medi\u00adcal AG, the company now has the oppor\u00adtu\u00adnity to leverage stra\u00adte\u00adgic syner\u00adgies, both in product deve\u00adlo\u00adp\u00adment and sales. The company\u2019s products comple\u00adment each other ideally, and the sales chan\u00adnels and target custo\u00admers with neuro\u00adcli\u00adnics, hospi\u00adtals and specialty distri\u00adbu\u00adtors are almost iden\u00adti\u00adcal. Toge\u00adther, the compa\u00adnies have the oppor\u00adtu\u00adnity to indi\u00advi\u00addua\u00adlize and opti\u00admize compre\u00adhen\u00adsive brain func\u00adtion monitoring.<\/p>\n
\u201cWe are deligh\u00adted to have found a part\u00adner in Luciole Medi\u00adcal AG that will enable us to offer further inno\u00adva\u00adtive products on the market and thus achieve an even better market posi\u00adtion,\u201d said Spie\u00adgel\u00adberg CEO Stefan Paschko<\/strong>.<\/p>\n \u201cSpie\u00adgel\u00adberg can be descri\u00adbed as the perfect addi\u00adtion to our product port\u00adfo\u00adlio. The signi\u00adfi\u00adcant growth of the company, the profi\u00adta\u00adble core busi\u00adness, but also the strong inter\u00adna\u00adtio\u00adnal presence of the company convin\u00adced us. We are looking forward to the upco\u00adming coope\u00adra\u00adtion and the nume\u00adrous oppor\u00adtu\u00adni\u00adties we will exploit toge\u00adther,\u201d explains Luciole CEO Phil\u00adippe Dro.<\/p>\n \u201cWe are plea\u00adsed to now trans\u00adfer our shares in Spie\u00adgel\u00adberg to a suita\u00adble part\u00adner after seve\u00adral successful years of colla\u00adbo\u00adra\u00adtion. This merger is the ideal synergy of two inno\u00adva\u00adtive compa\u00adnies that will enhance both market presence and treat\u00adment opti\u00adons in the field of cere\u00adbral health of the brain,\u201d says SHS Mana\u00adging Direc\u00adtor Uwe Stein\u00adba\u00adcher<\/strong>.<\/p>\n About Spie\u00adgel\u00adberg<\/strong><\/p>\n The medi\u00adcal tech\u00adno\u00adlogy company Spie\u00adgel\u00adberg GmbH & Co KG, based in Hamburg, was foun\u00added in 1986 by Dr. Andreas Spie\u00adgel\u00adberg. Spie\u00adgel\u00adberg deve\u00adlops, manu\u00adfac\u00adtures and markets products for intra\u00adcra\u00adnial pres\u00adsure measu\u00adre\u00adment, cere\u00adbro\u00ads\u00adpi\u00adnal fluid drai\u00adnage and IAP measu\u00adre\u00adment in more than sixty count\u00adries. The focus here is on relia\u00adbi\u00adlity, robust\u00adness and ease of use, so that work is made easier and the pati\u00aden\u00adt\u2019s treat\u00adment takes center stage. www.spiegelberg.de<\/p>\n About SHS Gesell\u00adschaft f\u00fcr Betei\u00adli\u00adgungs\u00adma\u00adnage\u00adment mbH<\/strong><\/p>\n SHS, an indus\u00adtry inves\u00adtor, is a private equity firm foun\u00added in 1993 that makes invest\u00adments in health\u00adcare compa\u00adnies in Europe. The focus of invest\u00adments is on expan\u00adsion finan\u00adcing, share\u00adhol\u00adder chan\u00adges and succes\u00adsion situa\u00adtions. \u201cBuil\u00adding Euro\u00adpean Health\u00adcare Cham\u00adpi\u00adons\u201d is the invest\u00adment philo\u00adso\u00adphy accor\u00adding to which SHS finan\u00adces and deve\u00adlops port\u00adfo\u00adlio compa\u00adnies. The T\u00fcbin\u00adgen-based inves\u00adtor is taking both mino\u00adrity and majo\u00adrity stakes. SHS funds\u2019 natio\u00adnal and inter\u00adna\u00adtio\u00adnal inves\u00adtors include pension funds, funds of funds, foun\u00adda\u00adti\u00adons, family offices, stra\u00adte\u00adgic inves\u00adtors, entre\u00adpre\u00adneurs and the SHS manage\u00adment team. The equity or equity-like invest\u00adment of the AIF is up to \u20ac40 million. Volu\u00admes beyond this can be imple\u00admen\u00adted with a network of co-inves\u00adtors. In its invest\u00adment decis\u00adi\u00adons, SHS places strong empha\u00adsis on the conside\u00adra\u00adtion of ESG aspects and has ther\u00ade\u00adfore commit\u00adted itself to the guide\u00adlines of the UN PRI. SHS is curr\u00adently inves\u00adt\u00ading from its sixth fund, which was laun\u00adched in 2022 and has a volume of appro\u00adxi\u00adm\u00adately \u20ac 250m. About Luciola Medical<\/strong><\/p>\n Luciole Medi\u00adcal AG was foun\u00added in Zurich, Switz\u00ader\u00adland and has rese\u00adar\u00adched and deve\u00adlo\u00adped a deep under\u00adstan\u00adding of brain hemo\u00addy\u00adna\u00admics to the field of brain moni\u00adto\u00adring. The company is led by an expe\u00adri\u00aden\u00adced manage\u00adment team and board of expe\u00adri\u00aden\u00adced medi\u00adcal tech\u00adno\u00adlogy execu\u00adti\u00adves and entre\u00adpre\u00adneurs. www.luciolemedical.com<\/p>\n <\/p>\n","protected":false},"excerpt":{"rendered":" T\u00fcbingen\/ Hamburg \u2014 German health\u00adcare specia\u00adlist SHS Capi\u00adtal is selling its stake in Spie\u00adgel\u00adberg to Luciole Medi\u00adcal AG. Spie\u00adgel\u00adberg, a medi\u00adcal tech\u00adno\u00adlogy company based in Hamburg, Germany, deve\u00adlops, produ\u00adces and distri\u00adbu\u00adtes highly specia\u00adli\u00adzed cathe\u00adters and measu\u00adring probes for neuro\u00adsur\u00adgi\u00adcal appli\u00adca\u00adti\u00adons in the brain and has been able to grow stron\u00adgly in recent years. Luciole Medical [\u2026]<\/p>\n","protected":false},"author":2,"featured_media":48859,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1366,1369,1371,1373],"tags":[],"class_list":["post-48955","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-news-en","category-investors","category-deals-en","category-venture-capital-en"],"yoast_head":"\n
\nwww.shs-capital.eu<\/p>\n